As of 2026-03-30, 帕博利珠单抗's data on the DeepSeek platform in the 医药行业 category shows: The overall mention rate is 4.08%, above the industry average by 2.6 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Positive mention rate (4.08%) is slightly higher than negative (0.00%), continue monitoring public sentiment. Among 6 competitors in the same category, 帕博利珠单抗's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
帕博利珠单抗's Mention Rate is 4.08%, lower than 0.6% of competitors
帕博利珠单抗's First Mention is 0.00%, lower than 0.9% of competitors
帕博利珠单抗's Preferred Rate is 0.00%, lower than 100.0% of competitors
帕博利珠单抗's Positive Rate is 4.08%, lower than 8.9% of competitors
帕博利珠单抗's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| KK药 | 8.16% | 0% | 0% | 2.04% | 4.08% | View Details |
| PPaxlovid | 6.12% | 0% | 0% | 4.08% | 2.04% | View Details |
| 立立普妥 | 6.12% | 0% | 0% | 4.08% | 0% | View Details |
| 达达格列净片 | 6.12% | 0% | 0% | 4.08% | 0% | View Details |
| MMounjaro | 4.08% | 0% | 0% | 2.04% | 0% | View Details |
| ZZepbound | 4.08% | 0% | 0% | 2.04% | 0% | View Details |
| 帕帕博利珠单抗 (Current Brand) | 4.08% | 0% | 0% | 4.08% | 0% | View Details |
